You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 149 No. 11, November 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (240)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Association Between Active Wegener's Granulomatosis and Anticytoplasmic Antibodies

Jan W. Cohen Tervaert, MD; Fokko J. van der Woude, MD; Anthony S. Fauci, MD; Julian L. Ambrus, MD; Jorge Velosa, MD; William F. Keane, MD; Sijtze Meijer, MD; Marijke van der Giessen, PhD; T. Hauw The, MD; Gjalt K. van der Hem, MD; Cees G. M. Kallenberg, MD

Arch Intern Med. 1989;149(11):2461-2465.


Abstract

• Autoantibodies reacting with the cytoplasm of granulocytes and monocytes (anticytoplasmic antibodies [ACPAs]) were found in 42 of 45 patients with active Wegener's granulomatosis (WG) (sensitivity, 93%). Specificity was tested in selected groups of patients with closely related diseases. Of 58 patients without a diagnosis of WG, 2 had ACPAs (specificity, 97%). The significance of ACPA titration for assessing or predicting disease activity was evaluated in a 16-month prospective study of 35 patients with WG. Seventeen relapses were observed and all were preceded by a significant rise of the ACPA titer. Anticytoplasmic antibodies are a specific and sensitive marker for active WG; a rising titer is a sensitive marker for the development of a relapse.

(Arch Intern Med. 1989;149:2461-2465)



Author Affiliations

From the Department of Internal Medicine, University Hospital, Groningen, the Netherlands (Drs Cohen Tervaert, van der Woude, Meijer, van der Giessen, The, van der Hem, and Kallenberg); The Laboratory of Immunoregulation, National Institutes of Health, Bethesda, Md (Drs Fauci and Ambrus); the Department of Internal Medicine, Mayo Clinic, Rochester, Minn (Dr Velosa); and the Nephrology Section, Hennepin County Medical Center, Minneapolis, Minn (Dr Keane).


Footnotes

Accepted for publication May 17, 1989.

Reprint requests to Department of Internal Medicine, University Hospital, Oostersingel 59, 9713 EZ Groningen, the Netherlands (Dr Cohen Tervaert).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Antimyeloperoxidase antibodies are a useful marker of disease activity in antineutrophil cytoplasmic antibody-associated vasculitides
Terrier et al.
Ann Rheum Dis 2009;68:1564-1571.
ABSTRACT | FULL TEXT  

CD4+CD25+ T-cell populations expressing CD134 and GITR are associated with disease activity in patients with Wegener's granulomatosis
Wilde et al.
Nephrol Dial Transplant 2009;24:161-171.
ABSTRACT | FULL TEXT  

Pathology Quiz Case 1: Diagnosis
Arch Otolaryngol Head Neck Surg 2008;134:1118-1119.
FULL TEXT  

Antibodies to Proteinase 3 Prime Human Oral, Lung, and Kidney Epithelial Cells To Secrete Proinflammatory Cytokines upon Stimulation with Agonists to Various Toll-Like Receptors, NOD1, and NOD2
Uehara et al.
CVI 2008;15:1060-1066.
ABSTRACT | FULL TEXT  

Antiproteinase 3 Antineutrophil Cytoplasmic Antibodies and Disease Activity in Wegener Granulomatosis
Finkielman et al.
ANN INTERN MED 2007;147:611-619.
ABSTRACT | FULL TEXT  

Increased Membrane Expression of Proteinase 3 during Neutrophil Adhesion in the Presence of Anti Proteinase 3 Antibodies
Brachemi et al.
J. Am. Soc. Nephrol. 2007;18:2330-2339.
ABSTRACT | FULL TEXT  

Renal histology in Chinese patients with anti-myeloperoxidase autoantibody-positive Wegener's granulomatosis
Chen et al.
Nephrol Dial Transplant 2007;22:139-145.
ABSTRACT | FULL TEXT  

Quantitation of Autoantibodies in Systemic Autoimmune Diseases: Clinically Useful?
Kallenberg et al.
Lupus 2006;15:397-402.
ABSTRACT  

Update in the diagnosis and management of pulmonary vasculitis.
Frankel et al.
Chest 2006;129:452-465.
ABSTRACT | FULL TEXT  

Pulmonary vasculitis.
Brown
Proc Am Thorac Soc 2006;3:48-57.
ABSTRACT | FULL TEXT  

Anti-proteinase 3 antibodies (c-ANCA) prime CD14-dependent leukocyte activation
Hattar et al.
J. Leukoc. Biol. 2005;78:992-1000.
ABSTRACT | FULL TEXT  

Aggravation of Anti-Myeloperoxidase Antibody-Induced Glomerulonephritis by Bacterial Lipopolysaccharide: Role of Tumor Necrosis Factor-{alpha}
Huugen et al.
Am. J. Pathol. 2005;167:47-58.
ABSTRACT | FULL TEXT  

Small vessel vasculitis of the lung
Frankel et al.
Chronic Respiratory Disease 2005;2:75-84.
ABSTRACT  

Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo
Pfister et al.
Blood 2004;104:1411-1418.
ABSTRACT | FULL TEXT  

The binding of proteinase 3 antineutrophil cytoplasmic antibodies (PR3-ANCA) varies in different ELISAs
Trevisin et al.
J. Clin. Pathol. 2004;57:303-308.
ABSTRACT | FULL TEXT  

Fc{gamma}RIIIb Allele-Sensitive Release of {alpha}-Defensins: Anti-Neutrophil Cytoplasmic Antibody-Induced Release of Chemotaxins
Tanaka et al.
J. Immunol. 2003;171:6090-6096.
ABSTRACT | FULL TEXT  

Monitoring Proteinase 3 Antineutrophil Cytoplasmic Antibodies for Detection of Relapses in Small Vessel Vasculitis
Segelmark et al.
CVI 2003;10:769-774.
ABSTRACT | FULL TEXT  

Neutrophil-activating potential of antineutrophil cytoplasm autoantibodies
Rarok et al.
J. Leukoc. Biol. 2003;74:3-15.
ABSTRACT | FULL TEXT  

Anti-neutrophil cytoplasmic antibody (ANCA) levels directed against proteinase-3 and myeloperoxidase are helpful in predicting disease relapse in ANCA-associated small-vessel vasculitis
Stegeman
Nephrol Dial Transplant 2002;17:2077-2080.
FULL TEXT  

Using Antineutrophil Cytoplasmic Antibody Testing to Diagnose Vasculitis: Can Test-Ordering Guidelines Improve Diagnostic Accuracy?
Mandl et al.
Arch Intern Med 2002;162:1509-1514.
ABSTRACT | FULL TEXT  

Wegener's granulomatosis: antiproteinase 3 antibodies induce monocyte cytokine and prostanoid release--role of autocrine cell activation
Hattar et al.
J. Leukoc. Biol. 2002;71:996-1004.
ABSTRACT | FULL TEXT  

Interaction of Antibodies to Proteinase 3 (Classic Anti-Neutrophil Cytoplasmic Antibody) with Human Renal Tubular Epithelial Cells: Impact on Signaling Events and Inflammatory Mediator Generation
Hattar et al.
J. Immunol. 2002;168:3057-3064.
ABSTRACT | FULL TEXT  

Detection of immune deposits in skin lesions of patients with Wegener's granulomatosis
Brons et al.
Ann Rheum Dis 2001;60:1097-1102.
ABSTRACT | FULL TEXT  

ANCA titres, even of IgG subclasses, and soluble CD14 fail to predict relapses in patients with ANCA-associated vasculitis
Nowack et al.
Nephrol Dial Transplant 2001;16:1631-1637.
ABSTRACT | FULL TEXT  

Anti-Proteinase 3 Antibody Activation of Neutrophils Can Be Inhibited by alpha 1-Antitrypsin
Rooney et al.
Am. J. Respir. Cell Mol. Bio. 2001;24:747-754.
ABSTRACT | FULL TEXT  

Proteinase 3, Wegener's autoantigen: from gene to antigen
van der Geld et al.
J. Leukoc. Biol. 2001;69:177-190.
ABSTRACT | FULL TEXT  

Are antineutrophil cytoplasmic antibodies a marker predictive of relapse in Wegener's granulomatosis? A prospective study
Girard et al.
Rheumatology (Oxford) 2001;40:147-151.
ABSTRACT | FULL TEXT  

Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity
Jayne et al.
QJM 2000;93:433-439.
ABSTRACT | FULL TEXT  

Titres of anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease are not related to disease activity
Roozendaal et al.
QJM 1999;92:651-658.
ABSTRACT | FULL TEXT  

Eosinophilia in Wegener’s Granulomatosis
Potter et al.
Chest 1999;116:1480-1483.
ABSTRACT | FULL TEXT  

Rare diseases bullet  3: Wegener's granulomatosis
Langford and Hoffman
Thorax 1999;54:629-637.
FULL TEXT  

High mobility group (HMG) non-histone chromosomal proteins HMG1 and HMG2 are significant target antigens of perinuclear anti-neutrophil cytoplasmic antibodies in autoimmune hepatitis
Sobajima et al.
Gut 1999;44:867-873.
ABSTRACT | FULL TEXT  

Active Wegener's Granulomatosis Is Associated with HLA-DR+ CD4+ T Cells Exhibiting an Unbalanced Th1-Type T Cell Cytokine Pattern: Reversal with IL-10
Ludviksson et al.
J. Immunol. 1998;160:3602-3609.
ABSTRACT | FULL TEXT  

Testing with Antineutrophil Cytoplasmic Antibody To Diagnose Wegener Granulomatosis
Hoffman
ANN INTERN MED 1996;125:622-622.
FULL TEXT  

Testing with Antineutrophil Cytoplasmic Antibody To Diagnose Wegener Granulomatosis
Rao and Allen
ANN INTERN MED 1996;125:622-623.
FULL TEXT  

Trimethoprim-Sulfamethoxazole (Co-Trimoxazole) for the Prevention of Relapses of Wegener's Granulomatosis
Stegeman et al.
NEJM 1996;335:16-20.
ABSTRACT | FULL TEXT  

The Role of Antineutrophil Cytoplasmic Antibody (c-ANCA) Testing in the Diagnosis of Wegener Granulomatosis: A Literature Review and Meta-analysis
Rao et al.
ANN INTERN MED 1995;123:925-932.
ABSTRACT | FULL TEXT  

Wegener's Granulomatosis
Sneller
JAMA 1995;273:1288-1291.
ABSTRACT  

Association of Chronic Nasal Carriage of Staphylococcus aureus and Higher Relapse Rates in Wegener Granulomatosis
Stegeman et al.
ANN INTERN MED 1994;120:12-17.
ABSTRACT | FULL TEXT  

Use and Interpretation of Diagnostic Immunologic Laboratory Tests
Lopez et al.
JAMA 1992;268:2970-2990.
ABSTRACT  

Autoantibodies Against Constituents of Neutrophils in the Diagnosis and Treatment of (Isolated) Subglottic Stenosis
de Vries et al.
Arch Otolaryngol Head Neck Surg 1992;118:1120-1123.
ABSTRACT  

Salivary Gland Involvement in Wegener's Granulomatosis
Specks et al.
Arch Otolaryngol Head Neck Surg 1991;117:218-223.
ABSTRACT  

Clinical Course of Anti-Neutrophil Cytoplasmic Autoantibody-associated Glomerulonephritis and Systemic Vasculitis
Falk et al.
ANN INTERN MED 1990;113:656-663.
ABSTRACT  

Immunotesting for Diagnosis in Rheumatic Diseases
GALL
Arch Intern Med 1989;149:2401-2402.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.